Physician profile
Willie V Melvin
NPI 1487741583
$89,005.41
in general payments reported to CMS, 2019-2025
30 companies · $3,368 in 2025
The $3,368 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $17K · 2021: $11K · 2022: $27K · 2023: $22K · 2024: $8,092 · 2025: $3,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $29K · Food and Beverage: $2,698 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $29,000.00 |
| Food and Beverage | $2,697.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $343.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $86,590.46 | 2020-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Endogastric Solutions, INC | $560.82 | 2019-2024 | Esophyx |
| Enterra Medical, INC. | $375.72 | 2022-2025 | |
| Stryker Corporation | $301.93 | 2022-2025 | Actishield Cf, Aequalis Ascend Flex, 1788 |
| Davol INC. | $133.10 | 2022 | |
| Evoke Pharma, INC. | $105.51 | 2024-2025 | |
| Tela Bio, INC. | $94.42 | 2020-2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $92.96 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $79.99 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $76.87 | 2025 | |
| Medtronic, INC. | $67.70 | 2021-2022 | |
| Acell, INC. | $55.97 | 2019-2020 | |
| Ambu INC. | $44.12 | 2022-2024 | |
| Ethicon US, LLC | $37.43 | 2024 | Harmonic, Echelon Circular, Echelon Flex |
| W. L. Gore & Associates, INC. | $37.15 | 2024 | Gore Enform Preperitoneal Biomaterial |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $36.90 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kowa Pharmaceuticals America, INC. | $34.51 | 2022-2023 | Seglentis |
| Solventum Corporation | $33.23 | 2024-2025 | Activ.A.C., V.A.C.Instill, V.A.C. Veraflo Cleanse Choice |
| Becton, Dickinson and Company | $30.12 | 2024 | Phasix Mesh |
| Teleflex LLC | $29.70 | 2019-2022 | |
| Covidien LP | $23.81 | 2019-2020 | |
| Bsn Medical INC | $23.76 | 2024 | |
| Innovation Technologies INC | $23.57 | 2025 | Irrisept |
| Lucid Diagnostics INC. | $23.37 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.19 | 2025 | Exparel |
| Aroa Biosurgery Incorporated | $15.73 | 2022 | |
| Triad Life Sciences INC. | $15.66 | 2022 | |
| Acera Surgical, INC. | $14.83 | 2024 | Restrata Wound Matrix |
| Cook Medical LLC | $14.52 | 2019 | |
| Smith+Nephew, INC. | $13.36 | 2023 | Collagenase Santyl, Regranex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Melvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.